SMH ETF has shown a robust bottoming signal, maintaining a bullish uptrend, and investors should consider adding exposure to ...

Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May ...